Highlights HeartBeam, Inc.

Equities

BEAT

US42238H1086

Market Closed - Nasdaq Other stock markets 21:30:00 15/05/2024 BST			5-day change	1st Jan Change
2.15 ^USD	+4.37%		+2.87%	-8.51%

05-09	Transcript : HeartBeam, Inc., Q1 2024 Earnings Call, May 09, 2024
05-09	HeartBeam, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HeartBeam, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09	CI
HeartBeam, Inc. Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias	04-09	CI
HeartBeam, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-20	CI
HeartBeam, Inc. Announces First Patients Enrolled in Pivotal Study Evaluating HeartBeam's AIMIGo System for Synthesizing A 12-Lead ECG	03-14	CI
HeartBeam, Inc. Receives Two New US Patents for Its Core Cardiac Monitoring Technology	03-07	CI
HeartBeam, Inc. Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights	12-14	CI
HeartBeam, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
HeartBeam, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23	CI
HeartBeam Signs New Collaboration Deal With Samsung; Shares Jump	30/05/23	MT
HeartBeam, Inc. Announces Automated Cardiac Detection Patent Granted for Heartbeam Aimigo™ System	25/05/23	CI
HeartBeam Files US FDA Application for HeartBeam AIMIGo System	18/05/23	MT
HeartBeam, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	11/05/23	CI
HEARTBEAM, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	16/03/23	AQ
HeartBeam, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	16/03/23	CI
HeartBeam, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	16/03/23	CI
HeartBeam Purchases LIVMOR Assets for Undisclosed Sum	14/03/23	MT
HeartBeam, Inc. acquired substantially all assets of LIVMOR, Inc.	13/03/23	CI
HeartBeam Receives European Patent for Signal Transformation from Vector Electrocardiogram to 12-Lead Electrocardiogram	05/01/23	CI
HeartBeam Expects AIMI System To Get Regulatory Nod in 'Near Future;' Shares Rise	29/12/22	MT
HeartBeam Issues Shareholder Letter and Provides Corporate Update	29/12/22	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights HeartBeam, Inc.

Equities

BEAT

US42238H1086

Highlights

Filters